Lynch Syndrome. A Patient s Guide to Genetic Testing for Lynch Syndrome

Similar documents
The Next Generation of Hereditary Cancer Testing

Lynch Syndrome. patient guide. genetic testing for hereditary colorectal and uterine cancer

Lynch Syndrome (HNPCC) and MYH-Associated Polyposis (MAP)

Result Navigator Positive Test Result: MSH6

Lynch Syndrome (HNPCC) and MYH-Associated Polyposis (MAP)

The benefit of. knowing. Genetic testing for hereditary cancer. A patient support guide

WELCOME. Taking Care of Your Health. April 30, 8 am to noon

patient guide PancNext genetic testing for hereditary pancreatic c a ncer Because knowing your risk can mean early detection and prevention

Understanding and Managing Lynch Syndrome

Information for You and Your Family

A Patient s Guide to risk assessment. Hereditary Colorectal Cancer

patient guide Hereditary Cancer genetic testing panels Because knowing your risk can mean early detection and prevention

Hereditary Gynecologic Cancer

How common are mutations in the MSH2 gene? 1. Mutations that cause Lynch syndrome are rare found in approximately 1 in 370 individuals.

Hereditary Colorectal Cancer

OvaNext. patient guide. genetic testing for hereditary breast, ovarian, and uterine cancer

patient guide ProstateNext genetic testing for hereditary prostate cancer Because knowing your risk can mean early detection and prevention

LYNCH SYNDROME: IN YOUR FACE BUT LOST IN SPACE (MOUNTAIN)!

Risk of Colorectal Cancer (CRC) Hereditary Syndromes in GI Cancer GENETIC MALPRACTICE

COLON CANCER & GENETICS VERMONT COLORECTAL CANCER SUMMIT NOVEMBER 15, 2014

MLH1 gene. Associated Syndrome Name: Lynch syndrome/hereditary NonPolyposis Colorectal Cancer (HNPCC) MLH1 Summary Cancer Risk Table

What a history of cancer may mean for you and your family and the steps you can take to reduce the risk

patient guide RenalNext genetic testing for hereditary kidney cancer Because knowing your risk can mean early detection and prevention

MSH6 gene. Associated Syndrome Name: Lynch syndrome/hereditary NonPolyposis Colorectal Cancer (HNPCC) MSH6 Summary Cancer Risk Table

patient guide CancerNext genetic testing for hereditary cancer Because knowing your risk can mean early detection and prevention

TumorNext-Lynch. genetic testing for hereditary colorectal or uterine cancer

Universal Screening for Lynch Syndrome

Guidelines on Genetic Evaluation and Management of Lynch Syndrome: A Consensus Statement by the US Multi-Society Task Force on Colorectal Cancer

PMS2 gene. Associated Syndrome Name: Lynch syndrome/hereditary NonPolyposis Colorectal Cancer (HNPCC) PMS2 Summary Cancer Risk Table

Mr Chris Wakeman. General Surgeon University of Otago, Christchurch. 12:15-12:40 Management of Colorectal Cancer

Content. Diagnostic approach and clinical management of Lynch Syndrome: guidelines. Terminology. Identification of Lynch Syndrome

GYNplus: A Genetic Test for Hereditary Ovarian and/or Uterine Cancer

Understanding Your Genetic Test Result. Positive for a Deleterious Mutation or Suspected Deleterious

patient guide MelanomaNext genetic testing for hereditary melanoma Because knowing your risk can mean early detection and prevention

A Patient s Guide to Hereditary Cancer. Is Hereditary Cancer Testing Right for You?

TumorNext-HR D. patient guide. a test for ovarian cancer patients to identify hereditary and tumor-specific mutations

patient guide CancerNext-Expanded genetic testing for hereditary cancer Because knowing your risk can mean early detection and prevention

patient guide BrainTumorNext genetic testing for hereditary brain tumors Because knowing your risk can mean early detection and prevention

Are you at risk of Hereditary Cancer? Your Guide to the Answers

DO YOU HAVE A FAMILY HISTORY OF ONE OF THESE CANCERS? BREAST, OVARIAN, COLORECTAL, ENDOMETRIAL, PANCREAS, PROSTATE, STOMACH OR SKIN CANCERS?

FACT SHEET 49. What is meant by a family history of bowel cancer? What is bowel cancer? What causes bowel cancer?

12: BOWEL CANCER IN FAMILIES

Adenomatous Polyposis Syndromes (FAP/AFAP and MAP)

Hereditary Non Polyposis Colorectal Cancer(HNPCC) From clinic to genetics

A Review from the Genetic Counselor s Perspective

Familial and Hereditary Colon Cancer

GeneticsNow TM. A Guide to Testing Hereditary Conditions in Women & Men. Patient & Physician Information

Understanding Your Positive Result. A guide to understanding your risk and taking action

GYNplus. genetic testing for hereditary ovarian and/or uterine cancer

TumorNext-HR D. patient guide. a test for ovarian cancer patients to identify hereditary and tumor-specific mutations

Familial and Hereditary Colon Cancer

Importance of Family History in Gynecologic Cancer Prevention. Objectives. Genetic Counselors. Angela Thompson, MS, CGC

Assessment of Universal Mismatch repair (MMR) or Microsatellite Instability (MSI) testing in colorectal cancers.

Resource impact report: Molecular testing strategies for Lynch syndrome in people with colorectal cancer (DG27)

Genetic testing for Lynch Syndrome Information for people who have had a cancer and are eligible for genetic testing for Lynch Syndrome.

Primary Care Approach to Genetic Cancer Syndromes

GENETIC TESTING: WHAT DOES IT REALLY TELL YOU? Lori L. Ballinger, MS, CGC Licensed Genetic Counselor University of New Mexico Cancer Center

Policy Specific Section: Medical Necessity and Investigational / Experimental. October 14, 1998 March 28, 2014

Genetic Testing for Lynch Syndrome

COLON CANCER GENETICS (FOR SURGEONS) Mark W. Arnold MD Chief, Division of Colon and Rectal Surgery Professor of Surgery The Ohio State University

A patient s guide to understanding. Cancer. Screening

FAMILIAL COLORECTAL CANCER. Lyn Schofield Manager Familial Cancer Registry

Lynch Syndrome. Angie Strang, PGY2

Understanding Your Genetic Test Result. Positive for Two Copies of an MYH Mutation

GI Screening/Surveillance in Lynch Syndrome

Ovarian Cancer Causes, Risk Factors, and Prevention

Colon cancer: practical molecular diagnostics. Wade S. Samowitz, M.D. University of Utah and ARUP

patient guide BreastNext genetic testing for hereditary breast cancer Because knowing your risk can mean early detection and prevention

Guidelines for the assessment of mismatch repair (MMR) status in Colorectal Cancer

An Introduction to Serrated Polyposis Syndrome (SPS)

WHAT IS A GENE? CHROMOSOME DNA PROTEIN. A gene is made up of DNA. It carries instructions to make proteins.

So, now, that we have reviewed some basics of cancer genetics I will provide an overview of some common syndromes.

Cancer Genomics 101. BCCCP 2015 Annual Meeting

What All of Us Should Know About Cancer and Genetics

Wellness Along the Cancer Journey: Healthy Habits and Cancer Screening Revised October 2015 Chapter 7: Cancer Screening and Early Detection of Cancer

AllinaHealthSystems 1

BowelGene. How do I know if I am at risk? Families with hereditary bowel cancer generally show one or more of the following clues:

BRCA1 and BRCA2. patient guide. genetic testing for hereditary breast and ovarian cancer (hboc)

THE MODERN GYNECOLOGIC EXAMINATION & SCREENING FOR GYNECOLOGIC MALIGNANCIES

Measure Description. Denominator Statement

Prior Authorization. Additional Information:

GHUK BowelGene_2017.qxp_Layout 1 22/02/ :22 Page 3 BowelGene

Cancer Facts for Women

Adenomatous Polyposis Syndromes (FAP/AFAP and MAP)

Genetic Determinants, Risk Assessment and Management

COLORECTAL PATHWAY GROUP, MANCHESTER CANCER. Guidelines for the assessment of mismatch. Colorectal Cancer

Updates in Gynecologic Oncology. Todd Boren, MD Gynecologic Oncologist Chattanooga s Program in Women s Oncology Sept 8 th, 2018

Genetic Testing for Lynch Syndrome and Other Inherited Colon Cancer Syndromes

Yes when meets criteria below. Dean Health Plan covers when Medicare also covers the benefit.

Colorectal Cancer - Working in Partnership. David Baty Genetics, Ninewells Hospital

BRCAnowTM It s Your Decision

COLORECTAL PATHWAY GROUP, MANCHESTER CANCER. Guidelines for the assessment of mismatch. Colorectal Cancer

Genetic testing all you need to know

DIAGNOSTICS ASSESSMENT PROGRAMME Diagnostics consultation document

Serrated Polyps and a Classification of Colorectal Cancer

Transcription:

Lynch Syndrome A Patient s Guide to Genetic Testing for Lynch Syndrome

What is Lynch Syndrome? Lynch syndrome is an inherited condition that increases your risk of developing colon cancer and other cancers associated with this syndrome. Lynch syndrome is hereditary, which means it is caused by genetic changes that can be passed from parents to their children. Those with Lynch syndrome are much more likely to develop cancers associated with this syndrome at a younger age (before 50). Also, women with Lynch syndrome are much more likely than the general population to develop endometrial (uterine) cancer. Lynch syndrome, often called Hereditary Nonpolyposis Colorectal Cancer (HNPCC), affects both men and women. It increases the risk of a number of cancers, particularly cancers of the colon (large intestine) and rectum. Approximately 3%-5% of all colorectal cancers are caused by Lynch syndrome

People with Lynch syndrome also have an increased risk of developing cancers of the stomach, small intestine, liver, gallbladder ducts, upper urinary tract, brain, skin and prostate. In female patients, endometrial cancer is particularly linked to Lynch syndrome. Although Lynch syndrome was not originally linked to the development of colon polyps, people who have the syndrome have been shown to develop noncancerous polyps at an earlier age than the general population. Additionally, while colon polyps do not occur in greater numbers for those with Lynch syndrome than the general population, the polyps are more likely to become cancerous.

Families who have Lynch syndrome usually have more cases of colon cancer than would typically be expected. Those with Lynch syndrome have a 50%-80% higher than normal chance of developing colorectal cancer during his or her lifetime. Endometrial cancer, ovarian cancer, stomach cancer and other various types of aggressive cancers are also more likely to occur, often at a younger age. If you are diagnosed with Lynch syndrome, be sure to let your family members know. Your parents, children, sisters, and brothers would have a 50% (1 in 2) chance of having this condition too. Other close relatives are also at increased risk of having Lynch syndrome. If you test negative for Lynch syndrome, that means you do not carry your family s Lynch syndrome genetic mutation. If you do not carry the mutation, you cannot pass on Lynch syndrome to your children.

GoPath Laboratories offers genetic testing to determine if you have a genetic mutation that causes Lynch syndrome. If you are identified as being at an increased risk for Lynch syndrome, genetic testing can help assess your risk for developing cancer. If the test does find a mutation, there are options you have to reduce your risk of developing cancer. Your physician and a genetic counselor can help you decide whether or not genetic testing is right for you. What genetic testing for Lynch syndrome may reveal: This test can tell you if you have a mutation that causes Lynch syndrome. Although Lynch syndrome indicates a higher risk for cancer, not everyone with the mutation will develop cancer. Therefore, this test will not tell you whether or not you will develop cancer. Also, this test cannot determine whether or not your family members (parents, siblings, and children) will also have Lynch syndrome. However, it is possible that if you have the mutation, close family members may also have it. It is important to share this information with your family.

Lynch Syndrome: Increased Cancer Risk If you are found to have Lynch syndrome, you are at a greater risk for developing cancers associated with this syndrome. This increased risk is due to inherited genetic mutations that interfere with your DNA s ability to repair itself (often referred to as DNA mismatch repair or MMR). That means if something goes wrong with a cell--such as cancer forms--your body might not have the tools it needs to fix the problem. Estimated Cancer Risks and Screening Suggestions Associated with Lynch Syndrome Cancer Type Estimated Risk* Possible Screening Suggestions Based on Family History or Other Risk Factors Colorectal** Up to 80% Colonoscopy every one to two years, starting at ages 20-25 Endometrial 20% to 60% Endometrial biopsy, annually starting ages 30 to 35 Stomach 11% to 19% Upper endoscopy every 2 to 4 years starting at ages 30 to 35 years; testing and treatment for H. pylori Ovarian 9% to 12% Yearly pelvic examination and ultrasound, endometrial biopsy, starting ages 30 to 35 Hepatobiliary (Liver, bile duct, gallbladder) 2% to 7% AFP blood test and/or Ultrasound Urinary Tract 1 to 4% Possible urinalysis or urine cytology annually starting at ages 30 to 35 years * Estimates compiled by the American Society of Clinical Oncology (ASCO) ** The estimated lifetime risk of colorectal cancer for those with Lynch syndrome has a wide range, with 80% being the upper limit of that range. Estimates are for those with Lynch syndrome who are not having regular colonoscopy screenings. Regular screenings with colonoscopy significantly reduces this risk. Screening does not prevent cancer and cannot always find cancers when they are too small to be treated successfully.

Lynch Syndrome Screening: What to Expect, Step-by-Step 1). Review of your health history The first step in determining whether or not to proceed with genetic testing is to discuss your family health history with your doctor or a genetic counselor. If your physician or counselor determines that you may be a good fit for testing, your physician can order the test for you. If you need help finding a genetic counselor, please call GoPath Laboratories at 855-GOPATH9 to speak with someone who can help. 2). Consult with your insurance provider Coverage of Lynch syndrome testing depends on your insurance provider. Your doctor s office may be able to help by contacting your provider for you or by giving you information about your test including testing codes that will help your insurance provider determine whether or not the test is covered. (GoPath Labortories accepts insurance from most major carriers. If your insurance does not cover genetic testing, contact us for additional payment options.)

3). Taking the Test If you and your doctor decide that Lynch syndrome testing would be beneficial for you, and you are comfortable with your insurance and/or payment options, then your doctor will order the test. GoPath has created a series of tests that not only can detect the five basic genetic mutations most commonly associated with Lynch syndrome (called MLH1, MSH2, MSH6, PMS2 and EPCAM), but also can detect other genes identified as being linked to the syndrome. If you have not been diagnosed with cancer, the test can often be done through a simple blood draw. If you have been diagnosed with a Lynch syndrome-related cancer, your physician may take the following steps: How Your Doctor Runs the Test CRC bx, IHC for MMR Colorectal Cancer Biopsy, IHC for MMR MLH1/ PMS2 (15-20%) ALL Positive (80%) MSH2/MSH6 (2%) MLH1 Methylation MethylTek MSI-Molecular (-) (+) MSI-S/L MSI-H Sequence MLH1/PMS2 Stop Stop Sequence MLH1/MSH2 Sequence MSH2 4). Discuss the results with your doctor We know the testing process can be a stressful one, which is why we strive to provide you with results as quickly as possible, most often within 10-14 days. Once you receive your results, you can discuss them with your doctor and decide what course of action needs to be taken to reduce your risk of developing cancer.

Interpreting the Results: What do your results mean? A positive result does not necessarily mean you will develop cancer. A positive result simply means that you carry a mutation that puts you at a higher-than-average risk for developing certain cancers. If you do have a mutation, your doctor will discuss with you what your options are for lowering your risk for developing cancer. Common options may include: Increased cancer screenings (such as more frequent colonoscopies or starting them at an earlier age) Lifestyle changes (quitting smoking, cutting back on alcohol, etc.) Preventive Surgery Medications

Test Result Definitions: Positive Your test detected a Lynch syndrome mutation. This means you are at an increased risk for developing cancers associated with Lynch Syndrome and at an earlier age. Discuss your options with your healthcare provider on how you can be proactive in reducing your cancer risk. Negative Your test did not detect a Lynch syndrome mutation. It s possible that another gene or factor is responsible for the cancer in your family. Your healthcare provider can help you understand what your revised risk is, as well as how to proceed with managing your healthcare such as when and how often to have cancer screenings based on your personal and/or family history of cancer. Variant of Unknown Significance Your test results may include a term called Variant of Unknown Significance or VUS. This means that we have found a genetic mutation that we do not yet know much about. This alteration may not have been previously reported or may have been reported but we have inadequate or conflicting evidence regarding its impact on gene function. Your healthcare provider can help guide you on how to best manage your healthcare and when to have cancer screenings based on your personal and/or family history of cancer.

Who should consider having genetic testing for Lynch syndrome? Families with Lynch syndrome often have multiple members who have had cancer. Consider speaking with your physician or genetic counselor if you have experienced any of the following: You have had colon or uterine cancer before age 50 You have a relative who has tested positive for Lynch syndrome You have had two or more of the following cancers at any age: colon, uterine, ovarian, or stomach cancer You have a family history of colon, uterine, ovarian, or stomach cancers You have experienced abnormal tumor test results, either for colorectal or endometrial tumors

Is testing for Lynch syndrome right for you? To discover whether or not you are a candidate for Lynch syndrome genetic testing, consult both your physician and a genetic counselor. If you need help finding a counselor, contact GoPath Laboratories at 855.GOPATH9. Here are some additional online resources to help you learn more about Lynch syndrome and cancer: GoPathGenetics.com Cancer.net MySupport360.com ShareCancerSupport.org OncoLink.org CCAlliance.org IHaveLynchSyndrome.org CancerCare.org LynchCancers.com CancerSupportCommunity.org ColonCancerFoundation.org 1351 Barclay Boulevard Buffalo Grove, IL 60089 855.GOPATH9 855.467.2849 www.gopathlabs.com